Seaport Therapeutics, Inc. (SPTX)
19.98
-0.15
(-0.75%)
USD |
NASDAQ |
Nov 13, 16:00
19.93
-0.05
(-0.25%)
After-Hours: 19:59
Seaport Therapeutics Shareholders Equity (Quarterly) : 397.46M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 397.46M |
| June 30, 2026 | 422.60M |
| Date | Value |
|---|---|
| March 31, 2026 | 209.71M |
| December 31, 2025 | 232.78M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 81.53B |
| Bristol Myers Squibb Co. | 23.40B |
| Harmony Biosciences Holdings, Inc. | 1.072B |
| ANI Pharmaceuticals, Inc. | 637.11M |
| Corcept Therapeutics, Inc. | 833.74M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 417.62M |
| Total Liabilities (Quarterly) | 20.17M |
| Debt to Equity Ratio | 0.0118 |
| Current Ratio | 17.48 |
| Net Debt Paydown Yield | -0.09% |